Pharmabiz
 

Health Canada approval for Aurobindo's Citalopram Hydrobromide

Our Bureau, HyderabadMonday, March 6, 2006, 08:00 Hrs  [IST]

Aurobindo Pharma Ltd has received product approval from Health Canada for Citalopram Hydrobromide tablets 20 mg & 40 mg. Citalopram Hydrobromide tablets 20 mg & 40 mg is the first formulation approval in Canada. The company is already selling Citalopram Hydrobromide tablets in the US market. The company has established a subsidiary in Canada to serve the local market and also filed many dossiers. Citalopram Hydrobromide tablets are indicated in the treatment of depressive disorders. The API is manufactured at Unit 1 and the formulation facility of the company is already approved by Health Canada. Citalopram Hydrobromide tablets are a generic equivalent of Forest Laboratories' Celexa and belongs to selective serotonin reuptake inhibitors (SSRIs) class of medication.

 
[Close]